정신건강의학과 영역에서 사전동의
Informed Consent in Psychiatry
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Informed consent is the procedure that respects the autonomy of patients; doctors protect patients’choices and rights through informed consent. Competence and voluntariness are prerequisitefor the informed consent. In recent years, the necessity of informed consent from the Psychiatricdepartment has been raised. Regarding informed consent from the Psychiatric department,there is a need to consider from two perspectives: respect for the patient’s decisionmakingability and the psychiatrist’s legal self-protection. In competence and voluntariness,psychiatric patients were excluded due to lack of decision-making ability and willingness. However,not all psychiatric patients were able to perform the given task. Therefore, informed consentis needed in the point of view regarding the decision-making ability of psychiatric patients. Psychotropicmedications, particularly antipsychotics, can cause several side effects, including extrapyramidalsyndrome and metabolic syndrome. Therefore, preannouncement of these patientsfor these side effects is needed. However, when the informed consent is only applied to psychiatrichospitals, it may increase prejudices and misconceptions about psychiatric medications andtreatment. Therefore, the informed consent should first be considered carefully and thoughtfully.
Abstract
Informed consent is the procedure that respects the autonomy of patients; doctors protect patients’choices and rights through informed consent. Competence and voluntariness are prerequisitefor the informed consent. In recent years, the necessity of informed consent from the Psychiatricdepartment has been raised. Regarding informed consent from the Psychiatric department,there is a need to consider from two perspectives: respect for the patient’s decisionmakingability and the psychiatrist’s legal self-protection. In competence and voluntariness,psychiatric patients were excluded due to lack of decision-making ability and willingness. However,not all psychiatric patients were able to perform the given task. Therefore, informed consentis needed in the point of view regarding the decision-making ability of psychiatric patients. Psychotropicmedications, particularly antipsychotics, can cause several side effects, including extrapyramidalsyndrome and metabolic syndrome. Therefore, preannouncement of these patientsfor these side effects is needed. However, when the informed consent is only applied to psychiatrichospitals, it may increase prejudices and misconceptions about psychiatric medications andtreatment. Therefore, the informed consent should first be considered carefully and thoughtfully.
참고문헌 (30)
- 홍소연, "충분한 설명에 근거한 동의에서 환자의 의사결정능력 판단의 기준", 한국의료윤리학회지, 8(1), pp.44~59 (2005), 한국의료윤리학회
- Dalla-Vorgia P, "Is consent in medicine a concept only of modern times?", J Med Ethics, 27, pp.59~61 (2001)
- 최병인, "생명과학 연구윤리", pp.110~111 (2009), 지코사이언스
- Pellegrino E, "For the patient’s good", pp.149~ (1988), Oxford University Press
- Brody B, "Life and death decision making", pp.101~ (1988), Oxford University Press
- "의료법 시행규칙, 보건복지부령 제193호, 제 13조의 2", ~ (2013)
- "대법원 선고 79도1387 판결", ~ (1980)
- Beauchamp T, "Principles of biomedical ethics", pp.72~74 (2001), Oxford University Press
- Dochin A, "Understanding autonomy relationally: toward a reconfiguration of bioethics principles", Journal of Medicine and Philosophy, 26, pp.368~374 (2001)
- "정신보건법, 법률 제11005호", ~ (2011)
- "형법, 법률 제10259호", ~ (2010)
- Grisso T, "Mentally ill and non-mentally ill patients’ abilities to understand informed consent disclosures for medication", Law and Human Behavior, 15, pp.377~388 (1991)
- Kitamura F, "Method for assessment of competency to consent in the mentally ill: Rationale, development, and comparison with the medically ill", International Journal of Law and Psychiatry, 21, pp.223~244 (1998)
- "A declaration on the promotion of patient’s rights in Europe", WHO, ~ (1994)
- Simon, "Clinical psychiatry and law" (1987), American psychiatry press
- 2007년 중앙정신보건사업지원단 사업보고서, , 보건복지부, ~ (2007)
- 정인원, "정신보건심판위원회의 계속입원치료 심사에 관한 연구", 신경정신의학, 42(4) (2003), 대한신경정신의학회
- 홍진표, "정신의료기관은 불법 감금의 공모자인가?", 신경정신의학회보, 53(2), pp.4~ (2013)
- , 1992
- 대한신경정신의학회, "신경정신의학", pp.650~ (2005), 중앙문화사
- Liperoti R, "Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents", Arch Int Med, 165, pp.2677~2682 (2005)
- Patricia R, "Managing risk when considering the use of atypical antipsychotics for elderly patients with dementia-related psychosis", Journal of Psychiatric Practice, 13, pp.143~152 (2007)
- "Minimum Data Sets Quality Measure/Indicator Report" (2010)[URL]
- "New Hampshire : US Food and Drug Administration ;2005 important drug warning and new information"[URL]
- "New Hampshire : US Food and Drug Administration;2004 Safety Alert:Zyprexa(olanzapine)"[URL]
- 이덕환, "의료행위와 법", pp.119~ (2006), 현문사
- Gutheil, Appelbaum, "Clinical handbook of psychiatry and the law", pp.160~ (1982), McGraw-hill book company
- 상고, 각공2012상, 565, , 2012
- David cohen, "A Model Consent Form for Psychiatric Drug Treatment", Journal of Humanistic Psychology, 40, pp.59~64 (2000)
- "City and county of San Francisco Department of Public health"[URL]